Samsung Display Gains Ground in U.S. Trade Secret Dispute Against BOE Over OLED Technology

Reporter Kim Jisun / approved : 2025-07-15 03:47:42
  • -
  • +
  • 인쇄

Photo: Samsung Display

 

 

[Alpha Biz= Kim Jisun] Seoul, July 14, 2025 — Samsung Display has secured a favorable preliminary ruling from the U.S. International Trade Commission (ITC) in its trade secret infringement case against Chinese display maker BOE.



According to industry sources on July 14, the ITC ruled on July 11 (local time) that BOE and its seven affiliates had violated Section 337 of the U.S. Tariff Act by misappropriating Samsung Display’s OLED (Organic Light-Emitting Diode) trade secrets.



The ITC recommended two key sanctions:

A Limited Exclusion Order—which would ban the import of OLED panels, modules, and components made using Samsung Display’s trade secrets into the United States.



A Cease and Desist Order—which would prohibit the marketing, distribution, sale, advertising, and offering for sale of related finished products in the U.S.



While the decision is a preliminary ruling, such findings are rarely overturned during the final determination. The ITC typically issues preliminary decisions following extensive investigations into alleged unfair trade practices.



If the ruling is finalized, BOE could face significant commercial setbacks, particularly in its efforts to supply OLED panels for Apple’s iPhone standard models—a key business segment.



Samsung Display originally filed the complaint in October 2023, accusing BOE of illegally acquiring and utilizing its proprietary OLED technologies. The ITC’s final ruling is scheduled for November 2025.

 

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Hanjin Group Moves Forward with Low-Cost Carrier (LCC) Consolidation Amid Financial Challenges2025.12.12
President Yoon Demands Strong Action on Coupang Data Breach During Ministry Reports2025.12.12
Fair Trade Commission Begins Review of Korean Air’s Guam Route Compliance Adjustment Request2025.12.12
Celltrion Executes KRW 782.4 Billion Capital Increase to Acquire Eli Lilly US Facility, Announces Record Dividends2025.12.12
GS Retail Employees Move to Establish Labor Union2025.12.12
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사